Percepção das mulheres brasileiras sobre os Contraceptivos Reversíveis de Longa Duração (LARCs)
##plugins.themes.bootstrap3.article.sidebar##
Publicado
May 7, 2024
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Analisar a relação da R/E com o processo de enfrentamento do uso abusivo de substâncias psicoativas, a partir das representações sociais de usuários de um Centro de Atenção Psicossocial Álcool e Outras Drogas. Métodos: Trata-se de um estudo qualitativo, do tipo descritivo, realizado em um Centro de Atenção Psicossocial Álcool e Outras Drogas, a partir da aplicação de entrevistas com roteiro semiestruturado com usuários do serviço. Resultados: A partir das análises dos dados, emergiram quatro categorias temáticas: Refletindo sobre os sentidos de espiritualidade e religiosidade; A influência de aspectos da religiosidade e espiritualidade; Abordagem de elementos espirituais e religiosos no tratamento obtido no CAPSad e; Inclusão de elementos religiosos e espirituais no tratamento obtido no CAPSad. Conclusão: Ao analisar as representações sociais de dependentes de álcool e outras drogas e os aspectos da religiosidade e espiritualidade, observou-se que estes são fortemente interligados com cotidiano deste grupo social, como um ponto de auxílio no enfrentamento do uso abusivo.
##plugins.themes.bootstrap3.article.details##
Como Citar
YoshiokaB. A., MunizL. B., AlcazarN. de C., OliveiraM. E. M. de, RudgeC. Z. M., OliveiraJ. B. de S., & JúdiceW. A. de S. (2024). Percepção das mulheres brasileiras sobre os Contraceptivos Reversíveis de Longa Duração (LARCs). Revista Eletrônica Acervo Saúde, 24(5), e15776. https://doi.org/10.25248/reas.e15776.2024
Seção
Artigos Originais
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. ARAÚJO FG, et al. Mix contraceptivo e fatores associados ao tipo de método usado pelas mulheres brasileiras: estudo transversal de base populacional. Cad Saúde Pública [Internet], 2023; 39(8): e00229322.
2. BAHAMONDES L, et al. Long-acting reversible contraceptive (LARCs) methods. Best Pract Res Clin Obstet Gynaecol, 2020; 66: 28-40.
3. BAPTISTA VF. A pílula contraceptiva na ótica da religião: observando a Pesquisa Nacional de Demografia e Saúde da Criança e da Mulher (PNDS-2006). Research, Society and Development, 2021; 10(10): e495101019289.
4. BLUMENBERG C, et al. Socio-demographic and economic inequalities in modern contraception in 11 low- and middle-income countries: an analysis of the PMA2020 surveys. Reprod Health, 2020; 17(1): 82.
5. BRANDÃO ER e CABRAL CD. From unplanned pregnancy to contraception: contributions to the debate. Cad Saúde Pública, 2017; 33(2): e00211216.
6. BRASIL. Portaria nº 3.265, de 1ºde Dezembro de 2017. Dispõe sobre a ampliação do acesso ao Dispositivo Intrauterino Tcu 380 (DIU de cobre) no âmbito do Sistema Único de Saúde (SUS). Disponível em: Acesso em 11/12/2023.
7. CAFFE S, et al. Looking back and moving forward: can we accelerate progress on adolescent pregnancy in the Americas? Reprod Health, 2017; 14(1): 83.
8. CHRISTOFIELD M, LACOSTE M. Accessible contraceptive implant removal services: an essential element of quality service delivery and scale-up. Glob Health Sci Pract, 2016; 4: 366–372.
9. DARNEY BG, et al. US “safety net” clinics provide access to effective contraception for adolescents and young women, 2017–2019. Am J Public Health, 2022a; 112: S555–S562.
10. DARNEY BG, et al. Title X improved access to most effective and moderately effective contraception in US safety-net clinics, 2016–18. Health Aff (Millwood), 2022b; 41: 497–506.
11. EECKHAUT MCW, et al. Who Is Using Long-Acting Reversible Contraceptive Methods? Findings from Nine Low-Fertility Countries. Perspectives on Sexual and Reproductive Health, 2014; 46(3):149–155.
12. ELA EJ, et al. Satisfaction, resignation, and dissatisfaction with long-acting reversible contraception among low-income postpartum Texans. Womens Health Issues, 2022; 32: 334–342.
13. EWERLING F, et al. Demand for family planning satisfied with modern methods among sexually active women in low- and middle-income countries: who is lagging behind? Reprod Health, 2018; 15(1): 1–10.
14. FAGAN T, et al. Family Planning in the Context of Latin America's Universal Health Coverage Agenda. Glob Health Sci Pract, 2017; 5(3): 382-398.
15. FEBRASGO. Contracepção reversível de longa ação. - - São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia, 2022. (Série Orientações e Recomendações FEBRASGO, no. 1/Comissão Nacional Especializada em Anticoncepção). ii, 44p [cited 2023 Mar Available from: https://www.febrasgo.org.br/media/k2/attachments/03-CONTRACEPCAO_REVERSIVEL_DE_LONGA_ACAO.pdf.
16. GANATRA B, et al. Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model. Lancet, 2017; 390(10110): 2372-2381.
17. GRADY WR, et al. Contraceptive method switching in the United States. Perspect Sex Reprod Health 2002; 34: 135–145.
18. GUPTE PR. India: “The Emergency” and the politics of mass sterilization. Educ About Asia, 2017; 22(3): 40–44.
19. HENRY D, et al. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana. Journal of Pediatric and Adolescent Gynecology. 2021; 34(4): 504-513.
20. JACINTO A, et al. Introducing long-acting contraceptive removal indicators in a pilot study in Mozambique: dynamics of discontinuation and implications for quality of care. Glob Health Sci Pract, 2022; 10: e2100252.
21. JACKSON E, GLASIER A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol, 2011; 117: 657-662.
22. JONES RK, et al. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health, 2002; 34(6): 294-303.
23. MACHADO RB, et al. Long-Acting Reversible Contraception. Rev Bras Ginecol Obstet [Internet], 2017; 39(6): 294–308.
24. MACHADO RB, et al. Different perceptions among women and their physicians regarding contraceptive counseling: results from the TANCO Survey in Brazil. Rev Bras Ginecol Obstet, 2020; 42(5): 255-265.
25. MAVRANEZOULI I. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Human Reproduction, 2008; 23(6), 1338–1345.
26. MINISTÉRIO DA SAÚDE. NT-DIU NOTA TÉCNICA Nº 21/2021-DAPES/SAPS/MS. inserção do Dispositivo Intrauterino e Contraceptivo (DIU) por enfermeiros. Brasília: Ministério da Saúde, Secretaria de Gestão do Trabalho e da Educação na Saúde, Departamento de Gestão da Educação em Saúde; 2021 Out. Disponível em: https://egestorab.saude.gov.br/image/?file=20211029_N_NTDIUenfermagem_5214792097250368643.pdf. Acesso em: 11/12/2023.
27. PANIZ VMV, et al. Conhecimento sobre anticoncepcionais em uma população de 15 anos ou mais de uma cidade do Sul do Brasil. Cad Saúde Pública [Internet], 2005; 21(6): 1747–1760.
28. PEIPERT JF, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol, 2011; 117: 1105–1113.
29. PONCE DE LEON RG, et al. Contraceptive Use in 23 Countries in Latin America and the Caribbean: Long-Acting Reversible Contraceptives Much Less Popular than Short-Acting Contraceptives. SSRN Electronic Journal, 2018; 7(2): e227–e235.
30. PONCE DE LEON RG, et al. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries. Lancet Glob Health, 2019; 7(2): e227–e235.
31. POLIS CB, et al. Typical-use contraceptive failure rates in 43 countries with Demographic and Health Survey data: summary of a detailed report. Contraception, 2016; 94(1): 11-17.
32. SAAVALA M. Understanding the prevalence of female sterilization in rural South India. Stud Fam Plann, 1999; 30(4): 288–301.
33. SHARMA DC. India’s sterilisation scandal. Lancet, 2014; 384(9961): e68–e69.
34. SIMMONS RG, et al. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Am J Obstet Gynecol, 2019; 220(4): 376.e1-376.e12.
35. SZNAJDER KK, et al. Incidence of discontinuation of long-acting reversible contraception among adolescent and young adult women served by an urban primary care clinic. J Pediatr Adolesc Gynecol, 2017; 30: 53–57.
36. TONG YW, et al. Acceptability of different mechanisms of action of contraception in women: a questionnaire survey. BMJ Sex Reprod Health, 2022; 48(2): 117-122.
37. TRUSSELL J. Contraceptive failure in the United States. Contraception, 2011; 83(5): 397-404.
38. UGAZ JI, et al. Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors. Int J Gynaecol Obstet, 2015;130 Suppl 3: E3-7.
39. WENDER MCO, et al. Influência da utilização de métodos contraceptivos sobre as taxas de gestação não planejada em mulheres brasileiras. Femina, 2022; 50(3): 134-141.
40. WYATT KD, et al. Women’s values in contraceptive choice: a systematic review of relevant attributes included in decision aids. BMC Womens Health, 2014; 14(1): 28.
2. BAHAMONDES L, et al. Long-acting reversible contraceptive (LARCs) methods. Best Pract Res Clin Obstet Gynaecol, 2020; 66: 28-40.
3. BAPTISTA VF. A pílula contraceptiva na ótica da religião: observando a Pesquisa Nacional de Demografia e Saúde da Criança e da Mulher (PNDS-2006). Research, Society and Development, 2021; 10(10): e495101019289.
4. BLUMENBERG C, et al. Socio-demographic and economic inequalities in modern contraception in 11 low- and middle-income countries: an analysis of the PMA2020 surveys. Reprod Health, 2020; 17(1): 82.
5. BRANDÃO ER e CABRAL CD. From unplanned pregnancy to contraception: contributions to the debate. Cad Saúde Pública, 2017; 33(2): e00211216.
6. BRASIL. Portaria nº 3.265, de 1ºde Dezembro de 2017. Dispõe sobre a ampliação do acesso ao Dispositivo Intrauterino Tcu 380 (DIU de cobre) no âmbito do Sistema Único de Saúde (SUS). Disponível em:
7. CAFFE S, et al. Looking back and moving forward: can we accelerate progress on adolescent pregnancy in the Americas? Reprod Health, 2017; 14(1): 83.
8. CHRISTOFIELD M, LACOSTE M. Accessible contraceptive implant removal services: an essential element of quality service delivery and scale-up. Glob Health Sci Pract, 2016; 4: 366–372.
9. DARNEY BG, et al. US “safety net” clinics provide access to effective contraception for adolescents and young women, 2017–2019. Am J Public Health, 2022a; 112: S555–S562.
10. DARNEY BG, et al. Title X improved access to most effective and moderately effective contraception in US safety-net clinics, 2016–18. Health Aff (Millwood), 2022b; 41: 497–506.
11. EECKHAUT MCW, et al. Who Is Using Long-Acting Reversible Contraceptive Methods? Findings from Nine Low-Fertility Countries. Perspectives on Sexual and Reproductive Health, 2014; 46(3):149–155.
12. ELA EJ, et al. Satisfaction, resignation, and dissatisfaction with long-acting reversible contraception among low-income postpartum Texans. Womens Health Issues, 2022; 32: 334–342.
13. EWERLING F, et al. Demand for family planning satisfied with modern methods among sexually active women in low- and middle-income countries: who is lagging behind? Reprod Health, 2018; 15(1): 1–10.
14. FAGAN T, et al. Family Planning in the Context of Latin America's Universal Health Coverage Agenda. Glob Health Sci Pract, 2017; 5(3): 382-398.
15. FEBRASGO. Contracepção reversível de longa ação. - - São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia, 2022. (Série Orientações e Recomendações FEBRASGO, no. 1/Comissão Nacional Especializada em Anticoncepção). ii, 44p [cited 2023 Mar Available from: https://www.febrasgo.org.br/media/k2/attachments/03-CONTRACEPCAO_REVERSIVEL_DE_LONGA_ACAO.pdf.
16. GANATRA B, et al. Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model. Lancet, 2017; 390(10110): 2372-2381.
17. GRADY WR, et al. Contraceptive method switching in the United States. Perspect Sex Reprod Health 2002; 34: 135–145.
18. GUPTE PR. India: “The Emergency” and the politics of mass sterilization. Educ About Asia, 2017; 22(3): 40–44.
19. HENRY D, et al. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana. Journal of Pediatric and Adolescent Gynecology. 2021; 34(4): 504-513.
20. JACINTO A, et al. Introducing long-acting contraceptive removal indicators in a pilot study in Mozambique: dynamics of discontinuation and implications for quality of care. Glob Health Sci Pract, 2022; 10: e2100252.
21. JACKSON E, GLASIER A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol, 2011; 117: 657-662.
22. JONES RK, et al. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health, 2002; 34(6): 294-303.
23. MACHADO RB, et al. Long-Acting Reversible Contraception. Rev Bras Ginecol Obstet [Internet], 2017; 39(6): 294–308.
24. MACHADO RB, et al. Different perceptions among women and their physicians regarding contraceptive counseling: results from the TANCO Survey in Brazil. Rev Bras Ginecol Obstet, 2020; 42(5): 255-265.
25. MAVRANEZOULI I. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Human Reproduction, 2008; 23(6), 1338–1345.
26. MINISTÉRIO DA SAÚDE. NT-DIU NOTA TÉCNICA Nº 21/2021-DAPES/SAPS/MS. inserção do Dispositivo Intrauterino e Contraceptivo (DIU) por enfermeiros. Brasília: Ministério da Saúde, Secretaria de Gestão do Trabalho e da Educação na Saúde, Departamento de Gestão da Educação em Saúde; 2021 Out. Disponível em: https://egestorab.saude.gov.br/image/?file=20211029_N_NTDIUenfermagem_5214792097250368643.pdf. Acesso em: 11/12/2023.
27. PANIZ VMV, et al. Conhecimento sobre anticoncepcionais em uma população de 15 anos ou mais de uma cidade do Sul do Brasil. Cad Saúde Pública [Internet], 2005; 21(6): 1747–1760.
28. PEIPERT JF, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol, 2011; 117: 1105–1113.
29. PONCE DE LEON RG, et al. Contraceptive Use in 23 Countries in Latin America and the Caribbean: Long-Acting Reversible Contraceptives Much Less Popular than Short-Acting Contraceptives. SSRN Electronic Journal, 2018; 7(2): e227–e235.
30. PONCE DE LEON RG, et al. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries. Lancet Glob Health, 2019; 7(2): e227–e235.
31. POLIS CB, et al. Typical-use contraceptive failure rates in 43 countries with Demographic and Health Survey data: summary of a detailed report. Contraception, 2016; 94(1): 11-17.
32. SAAVALA M. Understanding the prevalence of female sterilization in rural South India. Stud Fam Plann, 1999; 30(4): 288–301.
33. SHARMA DC. India’s sterilisation scandal. Lancet, 2014; 384(9961): e68–e69.
34. SIMMONS RG, et al. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Am J Obstet Gynecol, 2019; 220(4): 376.e1-376.e12.
35. SZNAJDER KK, et al. Incidence of discontinuation of long-acting reversible contraception among adolescent and young adult women served by an urban primary care clinic. J Pediatr Adolesc Gynecol, 2017; 30: 53–57.
36. TONG YW, et al. Acceptability of different mechanisms of action of contraception in women: a questionnaire survey. BMJ Sex Reprod Health, 2022; 48(2): 117-122.
37. TRUSSELL J. Contraceptive failure in the United States. Contraception, 2011; 83(5): 397-404.
38. UGAZ JI, et al. Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors. Int J Gynaecol Obstet, 2015;130 Suppl 3: E3-7.
39. WENDER MCO, et al. Influência da utilização de métodos contraceptivos sobre as taxas de gestação não planejada em mulheres brasileiras. Femina, 2022; 50(3): 134-141.
40. WYATT KD, et al. Women’s values in contraceptive choice: a systematic review of relevant attributes included in decision aids. BMC Womens Health, 2014; 14(1): 28.